Warnings
2-MMC (100%); Ketamine (2%) Pričakovano 4-MMC. Zaznano 2-MMC 100%, Ketamine 2%. Lokacija: Zürich, Švica. Datum: 2026-07-14. Vir: saferparty.ch.
Tabletka 2-MMC (100%); Ketamine (2%) — Zürich, Švica — 2026-07-14
Detected 2-MMC 100%, Ketamine 2%
Expected 4-MMC
Logo Unknown
Color white
Location Zürich, Switzerland
Date 2026-07-14
Source saferparty.ch
Media 1 image Appearance Color: white Media: 1 sample photo Expected vs Detected 4-MMC
Detected result: 2-MMC 100%, Ketamine 2%
Sample Details No additional sample descriptors available.
Testing Context Location: Zürich, Švica Date tested: 2026-07-14 Source: saferparty.ch Harm Reduction Similar-looking pills can contain different substances or strengths. Use drug checking services when available. Start low and avoid assuming a logo identifies the contents. SampleDNA Beta 2103 povezana opozorila · Spoznajte več o pogostih onesnaževalcih.
Povezani vzorci in kombinacije 2-MMC + Ketamine 30 vzorcev · Trenutni rezultat
Skupaj zaznano v povezavah rezultatov preverjanja drog.
Xanax logotip 212 vzorcev
Isti logotip se pojavi v povezanih rezultatih preverjanja drog.
Flualprazolam Xanax, 2 · Vienna, Avstrija · 2026-08-24 Methylclonazepam Xanax · Powys (LD3), Wales · 2026-07-23 Alprazolam Xanax · Kensington and Chelsea, Wandsworth, Westminster (SW1W), England · 2026-07-23 Bromazolam Xanax · Argyll and Bute, West Dunbartonshire (G82), Združeno kraljestvo · 2026-07-16 Alprazolam Xanax · City of Edinburgh, Midlothian (EH10), Združeno kraljestvo · 2026-07-16 Bromazolam Xanax · Kirklees (HD4), England · 2026-07-16 2-MMC + 4-MMC + Ketamine 2 vzorca
Skupaj zaznano v povezavah rezultatov preverjanja drog.
2-MMC + 2C-B + Ketamine + MDMA + Unknown 1 vzorec
Skupaj zaznano v povezavah rezultatov preverjanja drog.
2-MMC + 3-CMC + Caffeine + Cocaine + iso-LSD + Ketamine + LSD + MDMA + Methylon + Tertramisol (3,6µg (Mikrogramm)) 1 vzorec
Skupaj zaznano v povezavah rezultatov preverjanja drog.
Explorer SampleDNA
Links This static page is intended as the readable export baseline for crawler and low-capability delivery.